OXY
34
2
PH
73
3
ADI
60
5
MUR
39
3
ALLE
35
3
RCL
76
3
PDCO
63
2
FTI
58
5
GILD
63
-4
LH
42
6
EQIX
52
4
BDX
44
-2
AMGN
26
-4
CME
48
-4
CA
38
9
CMA
73
2
FSLR
46
2
HUM
33
3
PFG
52
-3
PEG
53
-2
OXY
34
2
PH
73
3
ADI
60
5
MUR
39
3
ALLE
35
3
RCL
76
3
PDCO
63
2
FTI
58
5
GILD
63
-4
LH
42
6
EQIX
52
4
BDX
44
-2
AMGN
26
-4
CME
48
-4
CA
38
9
CMA
73
2
FSLR
46
2
HUM
33
3
PFG
52
-3
PEG
53
-2
Financhill
Back

GiveMePower Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
16

GMPW
GiveMePower

Last Price:
$0.0100
Seasonality Move:
5.78%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.29
Seasonality Move:
1.75%
Sell
16
GiveMePower (GMPW) is a Sell

Is GiveMePower a Buy, Sell or Hold?

  • The current GiveMePower [GMPW] share price is $0.0056. The Score for GMPW is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • GMPW is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GMPW Stock Price Chart

What is GiveMePower's stock price today?

  • The GiveMePower share price today is $0.0056
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GMPW is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

GMPW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 41.77 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.0077 - 0.0077) Sell
Bollinger Bands (100): (0.0024 - 0.0224) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

GMPW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.01 Sell
20-day SMA: 0.01 Sell
50-day SMA: 0.01 Sell
200-day SMA: 0.02 Sell
8-day EMA: 0.01 Sell
20-day EMA: 0.01 Sell
50-day EMA: 0.01 Sell
200-day EMA: 0.02 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

GiveMePower Earnings Growth & GMPW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

GiveMePower Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):